Janney Montgomery Scott LLC Oramed Pharmaceuticals Inc. Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023
BUY
$5.88 - $12.03 $72,788 - $148,919
12,379 New
12,379 $149,000
Q1 2022

May 04, 2022
SELL
$8.19 - $13.89 $190,499 - $323,081
-23,260 Closed
0 $0
Q4 2021

Jan 27, 2022
BUY
$12.98 - $29.75 $36,110 - $82,764
2,782 Added 13.59%
23,260 $332,000
Q3 2021

Oct 29, 2021
BUY
$12.13 - $23.82 $248,398 - $487,785
20,478 New
20,478 $450,000

Others Institutions Holding ORMP

# of Institutions
63
Shares Held
7.4M
Call Options Held
4K
Put Options Held
2.1K
View Full List

About ORAMED PHARMACEUTICALS INC.

ORMP Quotes by TradingView
  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92.4M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email